欢迎来到麦多课文档分享! | 帮助中心 海量文档,免费浏览,给你所需,享你所想!
麦多课文档分享
全部分类
  • 标准规范>
  • 教学课件>
  • 考试资料>
  • 办公文档>
  • 学术论文>
  • 行业资料>
  • 易语言源码>
  • ImageVerifierCode 换一换
    首页 麦多课文档分享 > 资源分类 > PDF文档下载
    分享到微信 分享到微博 分享到QQ空间

    KS P ISO 5840-2007 Cardiovascular implants-Cardiac valve prostheses《心血管植入物 心脏瓣膜修复术》.pdf

    • 资源ID:820598       资源大小:1,022.37KB        全文页数:90页
    • 资源格式: PDF        下载积分:10000积分
    快捷下载 游客一键下载
    账号登录下载
    微信登录下载
    二维码
    微信扫一扫登录
    下载资源需要10000积分(如需开发票,请勿充值!)
    邮箱/手机:
    温馨提示:
    如需开发票,请勿充值!快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。
    如需开发票,请勿充值!如填写123,账号就是123,密码也是123。
    支付方式: 支付宝扫码支付    微信扫码支付   
    验证码:   换一换

    加入VIP,交流精品资源
     
    账号:
    密码:
    验证码:   换一换
      忘记密码?
        
    友情提示
    2、PDF文件下载后,可能会被浏览器默认打开,此种情况可以点击浏览器菜单,保存网页到桌面,就可以正常下载了。
    3、本站不支持迅雷下载,请使用电脑自带的IE浏览器,或者360浏览器、谷歌浏览器下载即可。
    4、本站资源下载后的文档和图纸-无水印,预览文档经过压缩,下载后原文更清晰。
    5、试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。

    KS P ISO 5840-2007 Cardiovascular implants-Cardiac valve prostheses《心血管植入物 心脏瓣膜修复术》.pdf

    1、 KSKSKSKS KSKSKSK KSKSKS KSKSK KSKS KSK KS KS P ISO 5840 KS P ISO 5840: 2007 (2012 ) 2007 10 31 http: /www.kats.go.krKS P ISO 5840: 2007 : ( ) ( ) () ( ) : (http:/www.standard.go.kr) : :2002 6 29 :2007 10 31 :2012 12 6 : 20120679 : ( 02-509-7294) (http:/www.kats.go.kr). 10 5 , . KS P ISO 5840: 2007

    2、i .1 1 1 2 1 3 .2 4 11 5 12 6 .12 6.1 12 6.2 12 6.3 13 6.4 ( )14 6.5 14 7 / .15 7.1 15 7.2 16 7.3 .19 7.4 21 A( ) 26 B( ) .29 C( ) .31 D( ) .38 E( ) .44 F( ) 45 G( ) 47 H( ) .50 I( ) .53 J( ) 54 K( ) .57 L( ) .62 M( ) 68 N( ) .70 O( ) 72 KS P ISO 5840: 2007 ii P( ) .77 Q( ) 78 R( ) .80 S( ) .82 83 K

    3、S P ISO 5840: 2007 (2012 ) Cardiovascular implants Cardiac valve prostheses 2005 4 ISO 5840, Cardiovascular implants Cardiac valve prostheses , . 1 1.1 . 1.2 , . 1.3 . . , , . . 1.4 / . 1.5 . A . 2 . . ( ) . KS P ISO 10993 1: 2007, 1: KS P ISO 11134: 2003, KS P ISO 11135: 2003, KS P ISO 11137: 2003,

    4、 KS P ISO 11607( ): 2007, KS P ISO 13485: 2007, ISO 9001 KS P ISO 14155 1: 2007, 1: KS P ISO 5840: 2007 2 KS P ISO 14630: 2003, KS X ISO 8601: 2003, ISO 10993 2: 1992, Biological evaluation of medical devices Part 2: Animal walfare requirements ISO 14160: 1998, Sterilization of single-use medical de

    5、vices incorporating materials of animal originValidation and routine control of sterilization by liquid chemical sterilants ISO 14937: 2000, Sterilization of health care products General requirements for characterization of a sterilizing agent and the development, validation and routine control of a

    6、 sterilization process for medical devices ISO 14971: 2000, Medical devices Application of risk management to medical devices EN 12442 1, Animal tissues and their derivatives utilized in the manufacture of medical devices Part 1: Analysis and management of risk EN 12442 2, Animal tissues and their d

    7、erivatives utilized in the manufacture of medical devices Part 2: Controls on sourcing, collection and handling EN 12442 3, Animal tissues and their derivatives utilized in the manufacture of medical devices Part 3: Validation of the elimination and/or inactivation of viruses and transmissible agent

    8、s Guidelines for reporting morbidity and mortality after cardiac valvular operations, American Association for Thoracic Surgery, European Association for Cardiothoracic Surgery, Society of Thoracic Surgeons, Annals of Thoracic Surgery, 62, pp. 932 935, 1996 3 . 3.1 (accessories) 3.2 (actuarial) “ (K

    9、aplan Meier)” “ (life table)” . 3.3 (anticoagulant-related haemorrhage) , , / . 3.4 (arterial diastolic pressure) 3.5 (arterial peak systolic pressure) 3.6 (back pressure) KS P ISO 5840: 2007 3 3.7 (blood-equivalent fluid) , 3.8 (closing volume) ( 1 ) 3.9 (control valve) , . 3.10 (cumulative inciden

    10、ce) “ ” . 3.11 (cycle) 3.12 (cycle rate) . / . 3.13 (design verification) KS P ISO 5840: 2007 4 1 3.14 (design validation) 3.15 (effective orifice area) AEO 3.16 (failure) . / . 3.17 (failure mode) (stent) , . 3.18 (flexible heart valve substitute) (occluder) . , . KS P ISO 5840: 2007 5 3.19 (forwar

    11、d-flow phase) 3.20 (hazard) (harm) 3.21 (harm) A ISO/IEC Guide 51: 200314 3.3 . 3.22 (heart valve substitute) (3.18, 3.48 J.1, J.2, J.3, J.4, J.5 ) 3.23 (intended use) , , 3.24 (internal orifice area) IOA ( 2 ) 3.25 (intra-annular sewing ring) ( 2 , 3.24, 3.66 3.70 ) 3.26 (intrasupra-annular sewing

    12、ring) ( 2 , 3.24, 3.66 3.70 ) KS P ISO 5840: 2007 6 (Key) 1 IOA 2 TAD 3 ESRD 2 3.27 ( ) isolated (aortic or mitral) heart valve substitute (7.4.4 ). 3.28 (leakage volume) ( 1 ). 3.29 (linearized rate) . , . 3.30 (long term follow-up) ( ) 3.31 (manufacturer) 3 , , , , 3.32 (mean arterial pressure) 1

    13、11 2 22 3 3 3 KS P ISO 5840: 2007 7 3.33 (mean pressure difference) “ (mean pressure gradient)” . 3.34 (nonstructural dysfunction) (thrombosis), (embolus), . (pannus) , , , . 3.35 (occluder) “leaflets” “cusps” . 3.36 (operative mortality) 30 3.37 (outflow tract profile height) , ( ) 3.38 (pannus) 3.

    14、39 (paravalvular leak) “perivalvular” . 3.40 (probability) 3.41 (process validation) . KS P ISO 5840: 2007 8 3.42 (profile height) 3.43 (prosthetic valve endocarditis) . , ( , , , ) . , . 3.44 (quasi-real time durability testing) (200 cycles/min) 3.45 (reference valve) , . , . . 3.46 (regurgitant fr

    15、action) 3.47 (regurgitant volume) . ( 1 ). 3.48 (rigid heart valve substitute) . , . 3.49 (risk) KS A ISO/IEC Guide 51: 200314 3.2 3.50 (risk analysis) KS P ISO 5840: 2007 9 KS A ISO/IEC Guide 51: 200314 3.10 . 3.51 (risk assessment) KS A ISO/IEC Guide 51: 200314 3.12 3.52 (risk control) . 3.53 (ris

    16、k estimation) 3.54 (risk evaluation) KS A ISO/IEC Guide 51: 200314 3.7 3.11 . 3.55 (risk management) , , , 3.56 (root mean square forward flow)(RMS forward flow) 1 (1) . 122vv12RMSd)(ttttqqtt= RMSvq : q(t) : t t1: t2: 2 RMSvq . 3.57 (safety) KS A ISO/IEC Guide 51: 200314 3.1 KS P ISO 5840: 2007 10 3

    17、.58 (severity) 3.59 (simulated cardiac output) 3.60 (special processes) 3.61 (sterile) 3.62 (sterility assurance level)(SAL) 3.63 (sterilization) 3.64 (stroke volume) 3.65 (structural deterioration) , . , , , , , . 3.66 (supra-annular sewing ring) ( 2 ) 3.67 (systemic embolism) , , , ( ) ( ) . . 40

    18、. KS P ISO 5840: 2007 11 3.68 (tissue annulus diameter)(TAD) 3.69 (validation) 3.70 (valve size) (TAD, mm) (: TAD ) A.7, Q.2.2 c), Q.2.3 b) Q.2.3 g) . 3.71 (valve thrombosis) , ( , ) . 3.72 (verification) 4 , . ABS (Body Surface Area) AEO (Effective Orifice Area) AF (Atrial Fibrilation) ALARP (As Lo

    19、w As Reasonably Practicable) AWT (Accelerated Wear Testing) BSE (Bovine Spongiform Encephalopathy) CFD (Computational Fluid Dynamics) ECG (Electrocardiogram) ESRD (External Sewing Ring Diameter) FEA (Finite Element Analysis) FMEA (Failure Mode and Effect Analysis) FTA (Fault Tree Analysis) IFU (Inst

    20、ructions For Use) INR (International Normalized Ratio) IOA (Internal Orifice Area) OPC (Objective Performance Criteria) PROB (Probability Rating) KS P ISO 5840: 2007 12 RIND (Reversible Ischemic Neurological Deficits) RPN (Risk Priority Number SEVPROB) SEV (Hazard Severity Rank) SEM (Scanning Electr

    21、on Microscopy) TAD (Tissue Annulus Diameter) 5 , . ISO 14971 KS P ISO 13485 . 6 6.1 , , . 6.2 6.2.1 , , , / , . 1 . 1 / 34 42 30 200 beats/min 3 15 L/min 25 100 mL mm Hg mm Hg mm Hg mm Hg 100 130 65 85 95 115 60 40 50 60 1 ( ) 140 159 90 99 123 150 2 ( ) 160 179 100 109 138 170 3 ( ) 180 209 110 119 155 195 4 ( ) 210 120 185 210 ( ) 300 160 230 300 KS P ISO 5840: 2007 13 6.2.2 6.2.2.1 (: , ). .


    注意事项

    本文(KS P ISO 5840-2007 Cardiovascular implants-Cardiac valve prostheses《心血管植入物 心脏瓣膜修复术》.pdf)为本站会员(hopesteam270)主动上传,麦多课文档分享仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知麦多课文档分享(点击联系客服),我们立即给予删除!




    关于我们 - 网站声明 - 网站地图 - 资源地图 - 友情链接 - 网站客服 - 联系我们

    copyright@ 2008-2019 麦多课文库(www.mydoc123.com)网站版权所有
    备案/许可证编号:苏ICP备17064731号-1 

    收起
    展开